IPOPLUS

3,079.4

-0.3 -0.01%

18 Jun 2026

NSE Listed · Pharmaceuticals

Ajanta Pharma Limited (AJANTPHARM)

Volume: 7,392Avg Vol 1W: 26,201Avg Vol 1M: 69,44752W Range:2,329.93,314.9
₹3,079.4 0.01%
Market Cap₹39,097 Cr
Current Price₹3,079.4
Previous Close₹3,079.7
High / Low (52w)₹3,314.9 / ₹2,329.9
Volume7,392
Avg Vol (1W)26,201
Avg Vol (1M)69,447
Stock P/E35.66
Book Value₹361.16
Dividend Yield0.9%
ROE23.33%
ROA17.16%
Revenue (TTM)
Revenue Growth10.44%
Profit Margin19.37%
Total Debt₹0 Cr
Shares Outstanding12 Cr
Face Value₹2
EPS (TTM)₹21.35
P/B8.48
Debt / Equity0.06
50 DMA₹3,072.72
200 DMA₹2,920.56
Day change-0.01%
Price Chart
3,079.4 26.44% · 1Y
3262238610.1L
2025-10-20
2026-06-16

20-day avg volume: 65K shares

Pros
  • Healthy return on equity of 23.3%.
  • Company is almost debt-free.
  • Revenue grew 10% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1,422 Cr₹1,375 Cr₹1,354 Cr₹1,303 Cr₹1,170 Cr₹1,146 Cr₹1,187 Cr₹1,145 Cr₹1,054 Cr₹1,105 Cr₹1,028 Cr₹1,021 Cr₹882 Cr₹972 Cr₹938 Cr₹951 Cr₹870 Cr₹838 Cr₹885 Cr₹748 Cr₹757 Cr₹749 Cr₹716 Cr₹668 Cr₹682 Cr
EBITDA₹349 Cr₹364 Cr₹344 Cr₹336 Cr₹275 Cr₹315 Cr₹296 Cr₹323 Cr₹280 Cr₹293 Cr₹278 Cr₹270 Cr₹153 Cr₹171 Cr₹204 Cr₹223 Cr₹205 Cr₹232 Cr₹261 Cr₹222 Cr₹231 Cr₹218 Cr₹251 Cr₹208 Cr₹182 Cr
Net Profit₹267 Cr₹274 Cr₹260 Cr₹255 Cr₹225 Cr₹233 Cr₹216 Cr₹246 Cr₹203 Cr₹210 Cr₹195 Cr₹208 Cr₹122 Cr₹135 Cr₹157 Cr₹175 Cr₹151 Cr₹192 Cr₹196 Cr₹174 Cr₹159 Cr₹177 Cr₹170 Cr₹148 Cr₹129 Cr
EPS21.3421.9120.8220.431818.5917.2619.5316.0916.6715.516.539.5410.512.2213.6317.722.1615.120.0818.420.4119.516.9314.8
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹4,743 Cr₹4,293 Cr₹3,841 Cr₹3,457 Cr₹2,916 Cr₹2,680 Cr
EBITDA₹1,210 Cr₹1,121 Cr₹751 Cr₹920 Cr₹908 Cr₹680 Cr
Net Profit₹920 Cr₹816 Cr₹588 Cr₹713 Cr₹654 Cr₹468 Cr
EPS73.5364.7745.8954.9675.0953.6
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹5,015 Cr₹4,638 Cr₹4,679 Cr₹4,056 Cr₹3,779 Cr₹3,319 Cr
Total Liabilities₹1,225 Cr₹1,071 Cr₹1,291 Cr₹791 Cr₹783 Cr₹720 Cr
Equity₹3,790 Cr₹3,567 Cr₹3,388 Cr₹3,264 Cr₹2,996 Cr₹2,599 Cr
Total Debt₹0 Cr₹0 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹1,480 Cr₹1,097 Cr₹943 Cr₹801 Cr₹807 Cr₹612 Cr
Investing₹-377 Cr₹65 Cr₹-560 Cr₹-74 Cr₹-282 Cr₹-224 Cr
Financing₹-733 Cr₹-1,051 Cr₹-108 Cr₹-460 Cr₹-318 Cr₹-129 Cr
Free Cash Flow₹1,162 Cr₹945 Cr₹769 Cr₹652 Cr₹635 Cr₹372 Cr
Shareholding
Promoter 66.25% Institutions 26.63% Public 7.12%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search